The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy

C Schmied, A Nowak, C Gruner, E Olinger, H Debaix… - Heart, 2016 - heart.bmj.com
Objective Best treatment outcomes in Fabry disease (FD) associated cardiomyopathy can be
obtained when treatment is started as early as possible. The rationale of this study was to …

The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.

C Schmied, A Nowak, C Gruner, E Olinger… - Heart (British Cardiac …, 2016 - sonar.ch
METHODS A retrospective analysis of patient data was performed from an observational,
longitudinal, prospective cohort. Treatment response was defined as absence or presence …

[引用][C] The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy

C Schmied, A Nowak, C Gruner, E Olinger, H Debaix… - Heart, 2016 - cir.nii.ac.jp
The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy

C Schmied, A Nowak, C Gruner, E Olinger, H Debaix… - Heart, 2016 - zora.uzh.ch
OBJECTIVE: Best treatment outcomes in Fabry disease (FD) associated cardiomyopathy
can be obtained when treatment is started as early as possible. The rationale of this study …

The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.

C Schmied, A Nowak, C Gruner, E Olinger… - Heart (British Cardiac …, 2016 - europepmc.org
Objective Best treatment outcomes in Fabry disease (FD) associated cardiomyopathy can be
obtained when treatment is started as early as possible. The rationale of this study was to …

The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy

C Schmied, A Nowak, C Gruner, E Olinger, H Debaix… - Heart, 2016 - search.proquest.com
Objective Best treatment outcomes in Fabry disease (FD) associated cardiomyopathy can be
obtained when treatment is started as early as possible. The rationale of this study was to …

The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.

C Schmied, A Nowak, C Gruner, E Olinger… - Heart (British Cardiac …, 2016 - folia.unifr.ch
METHODS A retrospective analysis of patient data was performed from an observational,
longitudinal, prospective cohort. Treatment response was defined as absence or presence …

The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy

C Schmied, A Nowak, C Gruner… - Heart (British …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective Best treatment outcomes in Fabry disease (FD) associated cardiomyopathy can be
obtained when treatment is started as early as possible. The rationale of this study was to …

The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy

C Schmied, A Nowak, C Gruner, E Olinger, H Debaix… - Heart, 2016 - heart.bmj.com
Objective Best treatment outcomes in Fabry disease (FD) associated cardiomyopathy can be
obtained when treatment is started as early as possible. The rationale of this study was to …